HPV Test Misses Twice the same number of Women Who Develop Cervical Cancer as Cotesting Kumar Jeetendra | July 17, 2020 A Health Trends research from researchers in Quest Diagnostics, Secaucus, NJ, and the University of Pittsburgh Medical Center demonstrates the human papillomavirus (HPV) screening evaluation is less likely to find cervical cancer and precancer compared to cotesting, a procedure that combines HPV and Pap (Papanicolaou evaluation by liquid-based cytology) testing with the exact same specimen1 …
Poor intimate hygiene linked to being one of the biggest causes of cervical cancer Kumar Jeetendra | October 22, 2020 Cervical cancer is becoming one of the emerging health burdens for womanhood. Cervical cancer is the fourth most common type of cancer for women worldwide, but also one of the most preventable types of cancer. Most cervical cancer cases are caused by the sexually transmitted human papilloma virus (HPV). According to the data released in 2018 by the HPV Centre, in India, cervical …
MRI screening and designated biopsies could diminish overdiagnoses of prostate malignant growth Kumar Jeetendra | July 10, 2021 Many countries do not have nationwide prostate-cancer screening. Current methods lead to overdiagnoses, unnecessary biopsies, and unnecessary biopsies. Researchers at Karolinska Institutet, Sweden, have published a new study in The New England Journal of Medicine. It shows that targeted biopsies and magnetic resonance imaging (MRI), could reduce overdiagnoses by up to half. These results were …
